GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,062,000 | -3.7% | 117,411 | +2.1% | 0.75% | +4.6% |
Q1 2022 | $5,259,000 | +16.7% | 115,026 | +15.4% | 0.72% | +17.3% |
Q4 2021 | $4,508,000 | +45.2% | 99,656 | +22.7% | 0.61% | +23.5% |
Q3 2021 | $3,104,000 | +13.2% | 81,235 | +18.0% | 0.50% | +8.5% |
Q2 2021 | $2,742,000 | +51.9% | 68,854 | +37.5% | 0.46% | +36.3% |
Q1 2021 | $1,805,000 | +86.9% | 50,070 | +90.8% | 0.34% | +52.7% |
Q4 2020 | $966,000 | +81.9% | 26,240 | +85.9% | 0.22% | +52.8% |
Q3 2020 | $531,000 | +106.6% | 14,112 | +124.2% | 0.14% | +69.4% |
Q2 2020 | $257,000 | – | 6,295 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |